Vermorken JB - Search Results

1

Dendritic cell therapy of cancer: can it fulfill its promise?

Vermorken JB, Van Tendeloo VF. Vermorken JB, et al. Expert Rev Anticancer Ther. 2003 Feb;3(1):1-3. doi: 10.1586/14737140.3.1.1. Expert Rev Anticancer Ther. 2003. PMID: 12597344 Review. No abstract available.

2

ESO-ESSO-ESTRO Multidisciplinary Course in Oncology for Medical Students: 4 Years of Experience (2016-2019).

Pavlidis N, Madry R, Peeters M, Sandrucci S, Markowska J, Peccatori F, Costa A, Eriksen JG, Ricardi U, Poetter R, Schrijvers D, Vermorken JB; in addition to a list of contributors. Pavlidis N, et al. Among authors: vermorken jb. J Cancer Educ. 2022 Aug;37(4):1239-1244. doi: 10.1007/s13187-020-01947-3. Epub 2021 Jan 2. J Cancer Educ. 2022. PMID: 33387267

3

Optimizing treatments for recurrent or metastatic head and neck squamous cell carcinoma.

Specenier P, Vermorken JB. Specenier P, et al. Among authors: vermorken jb. Expert Rev Anticancer Ther. 2018 Sep;18(9):901-915. doi: 10.1080/14737140.2018.1493925. Epub 2018 Jul 16. Expert Rev Anticancer Ther. 2018. PMID: 29999437 Review.

4

Recurrent head and neck cancer: current treatment and future prospects.

Specenier PM, Vermorken JB. Specenier PM, et al. Among authors: vermorken jb. Expert Rev Anticancer Ther. 2008 Mar;8(3):375-91. doi: 10.1586/14737140.8.3.375. Expert Rev Anticancer Ther. 2008. PMID: 18366286 Review.

5

Cetuximab in the treatment of squamous cell carcinoma of the head and neck.

Specenier P, Vermorken JB. Specenier P, et al. Among authors: vermorken jb. Expert Rev Anticancer Ther. 2011 Apr;11(4):511-24. doi: 10.1586/era.11.20. Expert Rev Anticancer Ther. 2011. PMID: 21504318 Review.

6

Adjuvant active specific immunotherapy of stage II and stage III colon cancer with an autologous tumor cell vaccine: first randomized phase III trials show promise.

Hanna MG Jr, Hoover HC Jr, Vermorken JB, Harris JE, Pinedo HM. Hanna MG Jr, et al. Among authors: vermorken jb. Vaccine. 2001 Mar 21;19(17-19):2576-82. doi: 10.1016/s0264-410x(00)00485-0. Vaccine. 2001. PMID: 11257395 Clinical Trial.

7

Neoadjuvant chemotherapy in head and neck cancer: should it be revisited?

Specenier PM, Vermorken JB. Specenier PM, et al. Among authors: vermorken jb. Cancer Lett. 2007 Oct 28;256(2):166-77. doi: 10.1016/j.canlet.2007.06.015. Epub 2007 Jul 27. Cancer Lett. 2007. PMID: 17673364 Review.

8

Cetuximab: its unique place in head and neck cancer treatment.

Specenier P, Vermorken JB. Specenier P, et al. Among authors: vermorken jb. Biologics. 2013;7:77-90. doi: 10.2147/BTT.S43628. Epub 2013 Apr 15. Biologics. 2013. PMID: 23723688 Free PMC article.

9

CONCERT-1, an additional piece in the puzzle of (bio)-(chemo)-radiation.

Specenier P, Vermorken JB. Specenier P, et al. Among authors: vermorken jb. Ann Transl Med. 2016 Nov;4(21):432. doi: 10.21037/atm.2016.11.25. Ann Transl Med. 2016. PMID: 27942523 Free PMC article. No abstract available.

10

Optimal treatment for recurrent/metastatic head and neck cancer.

Vermorken JB, Specenier P. Vermorken JB, et al. Ann Oncol. 2010 Oct;21 Suppl 7:vii252-61. doi: 10.1093/annonc/mdq453. Ann Oncol. 2010. PMID: 20943624 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

537 results

Search Page